|
Authors | Year | Age/sex | Dabigatran dose | Reason for anticoagulation | Comorbidities | Complication | Attempted reversal (other than holding dabigatran) | Outcome |
|
Chen et al. [3] | 2013 | 80/M | 150 mg orally once a day | Atrial fibrillation | CKD stage 3, hypothyroidism | Hemoptysis | FFP, HD | Bleeding ceased with HD |
Fountzilas et al. [4] | 2013 | 82/F | 150 mg orally twice a day | Atrial fibrillation | CHF, CAD, HTN, AKI | Dabigatran toxicity (thrombin time >120 sec, aPTT 135 sec) | | Toxicity resolved |
Lal and Van Heukelom [5] | 2012 | 81/F | 150 mg orally once a day | Atrial fibrillation | DM, CKD stage 3, HTN | Surgical site hematoma | FFP, vitamin K | No further bleeding after hematoma evacuation |
Lal and Van Heukelom [5] | 2012 | 76/M | 150 mg orally twice a day | Atrial flutter | CAD, CHF, HTN | Colonic anastomosis site bleed | | No further bleeding |
Lal and Van Heukelom [5] | 2012 | 64/F | Unknown | Atrial fibrillation | CAD, Diastolic CHF, CVA, AKI | GI bleed, subclavian catheter insertion site bleed, SAH | FFP, desmopressin, vitamin K, apheresis platelet concentrate, HD | Bleeding stopped, however patient made comfort care due to pneumonia and multiple comorbidities |
Lal and Van Heukelom [5] | 2012 | 80/F | 150 mg orally twice a day | Atrial fibrillation | CKD stage 3, HTN | SAH, subdural hemorrhages, intragluteal hemorrhage | FFP, HD | Patient made comfort care |
Chang et al. [6] | 2013 | 94/M | 150 mg orally twice a day | Atrial fibrillation | | Fall with large subdural hematoma compressing the right lateral ventricle | Factor VIII inhibitor (FEIBA; Baxter Healthcare Corporation), HD | Clinical improvement with subsequent discharge to a rehabilitation facility |
Maddry et al. [7] | 2013 | 74/M | 150 mg orally twice a day | Atrial fibrillation | AKI | GI bleed | FFP, prothrombin complex concentrate, recombinant factor VIIa, HD | Patient died due to sepsis and DIC |
|